MIST
Milestone Pharmaceuticals Inc. · Healthcare
Insiders sold $1.1M net in the last 90 days ·5 sellers, 0 buyers· 1 of 11 sales under Rule 10b5-1 plans· latest Form 4 filed Apr 20, 2026
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$1.2M
reported sales (SEC code S)
Unique Insiders
5
in the rolling window
Latest filing
Apr 20, 2026
Oliveto Joseph
Milestone Pharmaceuticals Inc. (MIST) has 8 SEC Form 4 filings (24 transaction rows) in the rolling window, disclosed by 5 distinct insiders. Most recent filing: Apr 20, 2026.
Inside the rolling window, 5 insiders at Milestone Pharmaceuticals Inc. reported no open-market purchases and 13 open-market sales totaling $1.2M. The most active filer is President and CEO Oliveto Joseph with 5 filings. Insiders have net sold $1.2M over the trailing 6 months. The most recent open-market filing is a sale of 36,500 shares by President and CEO Oliveto Joseph, dated Apr 16, 2026, worth $82K.
- Industry:Biotechnology
- CEO:Joseph G. Oliveto
- Employees:38
- HQ:Montreal, QC, CA
- IPO:2019-05-09
| Source | |||||||
|---|---|---|---|---|---|---|---|
| President and CEO | Sale | 36,500 | $82K | Apr 20 | — | SEC ↗ | |
| President and CEO | Sale | 133,054 | $309K | Jan 28 | — | SEC ↗ | |
| President and CEO | Sale | 34,523 | $67K | Jan 28 | — | SEC ↗ | |
Muller LorenzFirst filing | Chief Commercial Officer | Sale | 53,566 | $124K | Jan 28 | — | SEC ↗ |
Muller LorenzFirst filing | Chief Commercial Officer | Sale | 11,180 | $22K | Jan 28 | — | SEC ↗ |
Bharucha DavidFirst filing | Chief Medical Officer | Sale | 58,007 | $135K | Jan 28 | — | SEC ↗ |
Bharucha DavidFirst filing | Chief Medical Officer | Sale | 12,245 | $24K | Jan 28 | — | SEC ↗ |
Nelson Jeffrey EdwardFirst filing | Chief Operating Officer | Sale | 58,007 | $135K | Jan 28 | — | SEC ↗ |
Nelson Jeffrey EdwardFirst filing | Chief Operating Officer | Sale | 12,245 | $24K | Jan 28 | — | SEC ↗ |
Hasija AmitFirst filing | CFO & EVP of Corp. Development | Sale | 58,007 | $135K | Jan 28 | — | SEC ↗ |
Hasija AmitFirst filing | CFO & EVP of Corp. Development | Sale | 12,245 | $24K | Jan 28 | — | SEC ↗ |
Oliveto JosephFirst filing | President and CEO | Sale | 500 | $1K | Jan 9 | — | SEC ↗ |
Oliveto JosephFirst filing | President and CEO | Sale | 43,000 | $97K | Jan 9 | — | SEC ↗ |
Earnings: last 7 quarters
Frequently asked questions
How many SEC Form 4 insider filings does MIST have?
Milestone Pharmaceuticals Inc. (MIST) has 8 SEC Form 4 filings (24 transaction rows) in the rolling 365-day window, disclosed by 5 distinct insiders. Most recent filing: Apr 20, 2026.
When was the most recent SEC Form 4 filing for MIST?
The most recent Form 4 filing for MIST on Tracefour is dated Apr 20, 2026.
Who is the most active insider at MIST?
The most active SEC Form 4 filer at MIST in the rolling window is President and CEO Oliveto Joseph, with 5 filings.
What is the net insider flow at MIST over the last 6 months?
Over the trailing 180 days, insiders at MIST have net sold $1.2M based on SEC Form 4 disclosures.
What is the total insider buy and sell value at MIST in the current window?
Inside the rolling window, insiders at MIST bought $0 and sold $1.2M based on SEC Form 4 filings.
Can I get alerts for MIST insider trading?
Yes. Tracefour sends a free email when a new SEC Form 4 purchase or sale is filed at Milestone Pharmaceuticals Inc. (MIST). Alerts are set per company from the page itself, there is no paid tier, and each email links to the original filing on SEC EDGAR.
Related companies
Milestone Pharmaceuticals Inc. is in the Healthcare sector.